查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球戒烟与尼古丁戒烟市场
市场调查报告书
商品编码
1380449

2023-2030 年全球戒烟与尼古丁戒烟市场

Global Smoking Cessation and Nicotine De-addiction Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 195 Pages | 商品交期: 2-3个工作天内

价格

细分市场前景

全球戒烟和尼古丁戒烟市场根据类型和配销通路进行细分。根据类型，市场分为 NTR、药物治疗、电子烟。根据配销通路，市场分为医院药房、药局、零售店和网路商店。在配销通路中，医院药房细分市场由于产品标准和消费者信任的良好保证，预计将占据相当大的市场份额。在大多数国家，尼古丁口香糖和其他尼古丁替代产品的销售仅限于药局。

NTR细分市场预计将在全球戒烟和尼古丁戒烟市场中占据显着份额

在这些类型中，NTR 细分市场由于其易用性、可及性增加以及减少吸烟者对尼古丁渴望的有效性，预计将占据显着的市场份额。 NTR 以口香糖、贴片、喷雾、吸入器或含片的形式提供单独的尼古丁，但不提供烟草中的其他有害化学物质。 NRT 可以帮助缓解一些身体戒断症状，以便您可以专注于戒烟的心理（情绪）方面。据世界卫生组织称，烟草流行对全球公共卫生危害最大，每年造成超过 800 万人死亡。其中约 130 万人是由非吸烟者接触二手烟造成的，而超过 700 万人是由直接吸烟造成的。 NRT 产品能够有效帮助人们戒烟，并被广泛用于戒烟困难的吸烟者。 2017 年至 2020 年间，场外 NTR 销售额每年总计约 10 亿美元。 2020年，含片占非处方尼古丁替代疗法销售额的33.3%（3.22亿美元），口香糖占52.7%（5.11亿美元），贴片占非处方尼古丁替代疗法销售额的14.1%（1.37亿美元） 。药局在非处方尼古丁替代疗法总销售额中所占比例最大（42.9%）。

区域展望

全球戒烟和尼古丁戒烟市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（义大利、西班牙、德国、法国等）、亚太地区（印度、中国、日本） 、韩国等）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，欧洲区域市场预计在预测期内将大幅成长。含尼古丁的OTC戒烟产品是英国等国最受欢迎的尼古丁替代疗法（NRT）产品。公众对戒烟好处的认识不断提高以及戒烟计画数量的增加推动了欧洲市场的发展。

北美预计将在全球戒烟和尼古丁戒烟中占据显着份额

由于发达的医疗基础设施以及可自由支配支出的收入不断增长，北美在戒烟和尼古丁戒烟市场中占据主导地位。根据美国医学会（AMA）的数据，2020年美国医疗保健支出成长9.7%，达到4.1兆美元，即人均12,530美元。该地区对电子烟产品的强劲需求也对北美戒烟和尼古丁脱瘾市场的成长起到了重要作用。电子烟是第二常用的烟草产品，2019 年有 4.5%（1,090 万）的美国成年人使用过该产品。预计由于偏好的转变，北美地区将以显着的速度扩张各国消费者倾向于使用植物性尼古丁戒瘾相关产品的情况。

市场参与者展望

服务全球戒烟和尼古丁戒烟市场的主要公司包括：英美烟草公司、雷迪博士实验室有限公司、葛兰素史克公司、帝国品牌公司、日本烟草公司、JUUL Labs, Inc.、菲利普莫里斯国际公司Inc.、Niconovum AB、Perrigo Company plc、OncoGenex Pharmaceuticals Inc、NJOY, LLC、InnokinTechnology 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2020年5月，Cipla Health的戒烟品牌Nicotex与卡纳塔克邦和果阿邦政府合作，为在COVID-19爆发期间从事高度脆弱性的第一线工作人员提供尼古丁替代疗法（NRT）。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 全球戒烟和尼古丁戒烟市场的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Johnson & Johnson Services, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Pfizer, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Cipla Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按类型分類的全球戒烟和尼古丁戒烟市场
    • 尼古丁替代疗法 (NRT)
    • 药物治疗
    • 电子烟
  • 按配销通路分類的全球戒烟和尼古丁戒烟市场
    • 医院药房
    • 药局
    • 零售店
    • 网上商店

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • British American Tobacco Plc
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Imperial Brands Plc
  • Japan Tobacco, Inc.
  • JUUL Labs, Inc.
  • Philip Morris International Inc.
  • Niconovum AB
  • Perrigo Company plc,
  • OncoGenex Pharmaceuticals, Inc.
  • NJOY, LLC
  • Vaping Daily
  • InnokinTechnology
  • Snowplus
  • Ritchy group Ltd.
Product Code: OMR2027738

Title: Global Smoking Cessation and Nicotine De-Addiction Market Size, Share & Trends Analysis Report by Types (Nicotine Replacement Therapy (NRT), Drug Therapy, and E-Cigarettes), and by Distribution Channel (Hospitals Pharmacies, Drug Stores, Retail Stores, and Online Stores)Forecast Period (2023-2030).

Global smoking cessation and nicotine de-addiction market is anticipated to grow at a CAGR of 15.2 % during the forecast period. The smoking cessation and nicotine de-addiction market has witnessed significant growth due to health disadvantages of smoking such as lung cancer, cardiac diseases, and other respiratory problems, initiatives supported by governments to raise awareness about the harmful effects of smoking through the use of informational brochures, warning labels, dissuasive imagery on cigarette packages, television advertisements, and newspapers.

Segmental Outlook

The global smoking cessation and nicotine de-addiction market is segmented based on the type, and distribution channel. Based on the type, the market is sub-segmented into NTR, drug therapy, e-cigarettes. Based on distribution channel, the market is sub-segmented into hospitals pharmacies, drug stores, retail stores and online stores. Among the distribution channel, the hospitals pharmacies sub-segment is anticipated to hold a considerable share of the market due to good assurance of product standards and consumer trust. In most countries, sales of nicotine gum and other nicotine replacement products are restricted to pharmacy shops.

NTR Sub-Segment is Anticipated to Hold a Prominent Share in the Global Smoking cessation and nicotine de-addiction Market

Among the types, NTR sub-segment is anticipated to hold a prominent share of the market due to its ease of use, its increased accessibility, and its effectiveness in reducing the nicotine craving in smokers. NTR gives individual nicotine in the form of gum, patches, sprays, inhalers, or lozenges but not the other harmful chemicals in tobacco. NRT can help relieve some of the physical withdrawal symptoms so that you can focus on the psychological (emotional) aspects of quitting. According to WHO tobacco epidemic the greatest hazards to global public health, killing more than 8 million people annually. Around 1.3 million of those fatalities are caused by non-smokers being exposed to secondhand smoke, whereas more than 7 million are caused by direct tobacco use. NRT products have been effective in helping people quit smoking and are widely used among smokers struggling to quit. Between 2017 and 2020 over-the-counter NTR sales totaled about $1 billion annually. In 2020, lozenges accounted for 33.3 per cent ($322 million), gum accounted for 52.7% ($511 million) and patches accounted for 14.1% ($137 million) of over-the-counter nicotine replacement therapy sales. Drug stores were accounting for the largest percentage of total over-the-counter nicotine replacement therapy sales (42.9%).

Regional Outlook

The global smoking cessation and nicotine de-addiction market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Europe regional market is expected to grow considerably over the forecast period. Nicotine-containing OTC smoking cessation products are the most preferred nicotine replacement therapy (NRT) products in the countries such as UK. The market in Europe is being driven by increased public awareness of the advantages of quitting smoking and a rise in the number of smoking cessations programmes.

North America is Expected to Hold a Prominent Share in the Global Smoking cessation and nicotine de-addiction

North America is dominating the smoking cessation and nicotine de-addiction market, due to the developed healthcare infrastructure as well as the growing incomes available for discretionary spending. According to the American Medical Association (AMA), health spending in the US increased by 9.7% in 2020 and reached to $4.1 trillion or $12,530 per capita. Region's strong demand for e-cigarette products also played a major role in increasing smoking cessation and nicotine de-addiction market in North America. E-cigarettes were the second most commonly used tobacco product, with 4.5% (10.9 million) of the US adults reporting use of the product in 2019. It is anticipated that the North American region will expand at a significant rate due to the shifting preferences of consumers towards the utilization of plant-based, nicotine de-addiction-related products in countries.

Market Players Outlook

The major companies serving the global smoking cessation and nicotine de-addiction market include: British American Tobacco Plc, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco, Inc., JUUL Labs, Inc., Philip Morris International Inc., Niconovum AB, Perrigo Company plc, OncoGenex Pharmaceuticals Inc, NJOY, LLC, InnokinTechnology and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2020, Nicotex, Cipla Health's smoking cessation brand, collaborated with Karnataka and Goa governments to provide Nicotine Replacement Therapy (NRT) to frontline workers, who are engaged in field work under high vulnerability amidst the COVID-19 outbreak.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global smoking cessation and nicotine de-addiction market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Johnson & Johnson Services, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Pfizer, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Cipla Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Smoking Cessation and Nicotine De-addiction Market by Types
    • 4.1.1. Nicotine Replacement Therapy (NRT)
    • 4.1.2. Drug Therapy
    • 4.1.3. E-Cigarettes
  • 4.2. Global Smoking Cessation and Nicotine De-addiction Market by Distribution Channel
    • 4.2.1. Hospitals Pharmacies
    • 4.2.2. Drug Stores
    • 4.2.3. Retail Stores
    • 4.2.4. Online Stores

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. British American Tobacco Plc
  • 6.2. Dr. Reddy's Laboratories Ltd.
  • 6.3. GlaxoSmithKline Plc
  • 6.4. Imperial Brands Plc
  • 6.5. Japan Tobacco, Inc.
  • 6.6. JUUL Labs, Inc.
  • 6.7. Philip Morris International Inc.
  • 6.8. Niconovum AB
  • 6.9. Perrigo Company plc,
  • 6.10. OncoGenex Pharmaceuticals, Inc.
  • 6.11. NJOY, LLC
  • 6.12. Vaping Daily
  • 6.13. InnokinTechnology
  • 6.14. Snowplus
  • 6.15. Ritchy group Ltd.

LIST OF TABLES

  • 1. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY TYPES, 2022-2030 ($ MILLION)
  • 2. GLOBAL NTR SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL DRUG THERAPY SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL E-CIGARETTES SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY HOSPITALS PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY DRUG STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY RETAIL STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY ONLINE STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 14. EUROPEAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. EUROPEAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 16. EUROPEAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 17. ASIA- PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. ASIA- PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 19. ASIA- PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL NTR SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL DRUG THERAPY SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL E-CIGARETTES SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY HOSPITALS PHARMACIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY DRUG STORES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY RETAIL STORES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY ONLINE STORES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. US SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)